These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10172795)

  • 1. Drug treatment takes a hit. As substance abuse has surged among teens, coverage for care has been curtailed.
    Gardner J
    Mod Healthc; 1996 Oct; 26(43):66, 68, 70-2. PubMed ID: 10172795
    [No Abstract]   [Full Text] [Related]  

  • 2. Financing of substance abuse treatment for children and adolescents. Committee on Child Health Financing and Committee on Substance Abuse, American Academy of Pediatrics.
    Pediatrics; 1995 Feb; 95(2):308-10. PubMed ID: 7838656
    [No Abstract]   [Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Medicaid coverage in a program for Latino substance users.
    Bachman SS; Walter AW; Kuilan N; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):74-82. PubMed ID: 18222142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Michigan's substance abuse services: readiness for managed care.
    Stauffer M
    Behav Healthc Tomorrow; 1995; 4(4):57-8. PubMed ID: 10172404
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of Healthcare for Communities: a study of health care delivery for alcohol, drug abuse, and mental health conditions.
    Sturm R; Gresenz C; Sherbourne C; Minnium K; Klap R; Bhattacharya J; Farley D; Young AS; Burnam MA; Wells KB
    Inquiry; 1999; 36(2):221-33. PubMed ID: 10459376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmet substance abuse treatment need, health services utilization, and cost: a population-based emergency department study.
    Rockett IR; Putnam SL; Jia H; Chang CF; Smith GS
    Ann Emerg Med; 2005 Feb; 45(2):118-27. PubMed ID: 15671966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of comorbid major depression and substance use disorders on alcohol and drug treatment: results of a national survey.
    Grant BF
    NIDA Res Monogr; 1997; 172():4-15. PubMed ID: 9154262
    [No Abstract]   [Full Text] [Related]  

  • 13. Financing mental health services for adolescents: a position paper of the Society for Adolescent Medicine.
    Kapphahn CJ; Morreale MC; Rickert VI; Walker LR;
    J Adolesc Health; 2006 Sep; 39(3):456-8. PubMed ID: 16919815
    [No Abstract]   [Full Text] [Related]  

  • 14. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating managed mental health programs.
    Whitted GS; Kunnes R
    AAPPO J; 1993; 3(2):27-30. PubMed ID: 10171662
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of insurance status on drug abuse treatment completion.
    Garcia LM; McGeary KA; Shultz JM; McCoy CB
    J Health Care Finance; 1999; 26(1):40-7. PubMed ID: 10497750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol- and drug-related visits to hospital emergency departments: 1992 National Hospital Ambulatory Medical Care Survey.
    Nelson CR; Stussman BJ
    Adv Data; 1994 Aug; (251):1-16. PubMed ID: 10172116
    [No Abstract]   [Full Text] [Related]  

  • 19. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse treatment in the Commonwealth of Massachusetts: gaps, consequences and solutions.
    Brolin MF; Horgan C; Amaro H; Doonan M
    Issue Brief (Mass Health Policy Forum); 2005 Nov; (27):1-25. PubMed ID: 16302313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.